Nucitec S.A. de C.V.
Records under this name other than the patents Nucitec S.A. de C.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 7 of 7 · Back to Nucitec S.A. de C.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,056,134 | Single daily dosage form for prevention and treatment of metabolic syndrome Lapsed on the fee record Ended Jun 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 16, 2023 | From the USPTO record |
| US 8,790,714 | Compositions and methods for treatment and prevention of osteoarthritis Lapsed on the fee record Ended Jul 29, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 29, 2022 | From the USPTO record |
| US 8,779,006 | Compositions and methods for treatment and prevention of osteoarthritis Lapsed on the fee record Ended Jul 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 15, 2022 | From the USPTO record |
| US 8,536,362 | β-hydroxy-γ-aminophosphonates and methods for the preparation and use thereof Lapsed on the fee record Ended Sep 17, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 17, 2021 | From the USPTO record |
| US 8,324,185 | Composition for the treatment of obesity and hyperlipidemia Lapsed on the fee record Ended Dec 4, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2020 | From the USPTO record |
| US 9,492,466 | Beta-hydroxy-gamma-aminophosphonates for treating immune disorders Lapsed on the fee record Ended Nov 15, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 15, 2020 | From the USPTO record |
| US 8,178,515 | β-hydroxy-γ-aminophosphonates and methods for the preparation and use thereof Lapsed on the fee record Ended May 15, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2020 | From the USPTO record |